Red Amber List N to R

Guidance in the Red / Amber List serves ONLY to define where clinical and prescribing responsibility for the listed medicines should lie in terms of governance and safety.

  • Inclusion in this list does NOT imply the medicine has been accepted for use via Managed Entry, does NOT imply endorsement of use, and does NOT take account of the cost implications of use of a particular medicine.
  • Prescribers should use this list in conjunction with guidance on the Managed entry process for medicines, and the NI formulary which includes information on current cost effective choices.
  • As far as possible, new specialist medicines are added to the list at the point when they are granted a UK product licence. In some instances this may be prior to the medicine being launched.

The table below lists specialist medicines. Users should search by generic name where possible. Brand names listed are not exhaustive.

Show All Entries   A-B  C-D  E-J  K-M  N-R  S-Z

Approved NameExample Trade NamesContextStatusGuidanceNew Entry
Nabilone Red
Nafarelin Synarel When used for treatment of infertility Red
Naltrexone Nalorex Amber No Shared Care Guideline Required (Click for info)
NaMuscla® Myotonia Red
Natalizumab Tysabri Red
Necitumumab Portrazza Red
Neratinib Nerlynx Red
Nevirapine Viramune Red
Nilotinib Tasigna Red
Nintedanib Vargatef , Ofev Red
Niraparib Zejula Red
Nivolumab Opdivo Red
Nusinersen Spinraza Red
Obinutuzumab Gazyvaro Red
Ocrelizumab Ocrevus Red
Ocriplasmin Jetrea Red
Octocog alfa Advate Red
Octreotide Sandostatin Palliative Care Amber Octreotide Palliative Care Shared Care Guideline
Octreotide Sandostatin Neuroendocrine tumours and acromegaly. Within licence. Amber Octreotide Endocrinology Shared Care Guideline
Octreotide Sandostatin Outside licence (except Palliative Care) Red
Ofatumumab Arzerra Red
Olanzapine Long Acting Injection Zypadhera Red
Olaparib Lynparza Red
Olaratumab Red
Omalizumab Xolair Red
Osimertinib Tagrisso Red
Ozanimod Zeposia Red
Paclitaxel Red
Padeliporfin Tookad Red
Palbociclib Ibrance Red
Palivizumab Synagis Red
Pamidronate Disodium Aredia Red
Panobinostat Farydak Red
Parathyroid hormone subcutaneous injection Preotact Red
Paritaprevir + ritonavir + ombitasvir Viekirax Red
Paritaprevir + ritonavir + ombitasvir +/- dasabuvir Red
Pasireotide Signifor Red
Patisiran Onpattro Red
Pazopanib Votrient Red
Pegaspargase Oncaspar Red
Pegfilgrastim Neulasta Red
Peginterferon alfa PegIntron, ViraferonPeg, Pegasys Red
Peginterferon beta-1a Plegridy Red
Pegloticase Krystexxa Red
Pegvaliase Palynziq Red
Pegvisomant Somavert Red
Pembrolizumab Kytruda Red
Pemigatinib Pemazyre Red NEW
Penicillamine Distamine Amber Penicillamine Shared Care Guideline
Pentosan polysulfate sodium Red
Pergolide Celance Amber Pergolide Shared Care Guideline
Pertuzumab Perjeta Red
Phenelzine Nardil Amber No Shared Care Guideline Required (Click for info)
Phenylbutazone Butacote Red
Pirfenidone Esbriet Red
Pixantrone Pixuvri Red
Plerixafor Mozobil Red
Polatuzumab Polivy Red
Pomalidomide Imnovid Red
Ponatinib Iclusig Red
Posaconazole Noxafil Red
Procarbazine Red
Radium Xofigo Red
Raltegravir Isentress Red
Raltegravir + lamivudine Dutrebis Red
Ramucirumab Cyramza Red
Ranibizumab Lucentis Red
Ravulizumab Ultomiris Red
Regorafenib Stivarga Red
Reslizumab Cinqaero Red
Ribavirin Rebetol, Virazole, Copegus Red
Ribociclib Kisqali Red
Rilpivirine Edurant Red
Riluzole Rilutek Motor neurone disease. Supply will remain via secondary care Amber Riluzole Shared Care Guideline
Riociguat Adempas Red
Risankizumab Skyrizi Red
Ritonavir Norvir Red
Rituximab MabThera Red
Romiplostim injection Nplate Red
Romosozumab Red
Ropeginterferon alfa-2b Besremi
Rucaparib Rucaparib Red
Ruxolitinib Jakavi Red

Show All Entries